Finance
German medical tech firm Brainlab plans Frankfurt IPO in coming weeks
Published by Global Banking & Finance Review®
Posted on June 12, 2025
2 min readLast updated: January 23, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on June 12, 2025
2 min readLast updated: January 23, 2026
Brainlab plans to launch an IPO on the Frankfurt Stock Exchange, aiming to raise €200 million for business expansion and balance sheet strengthening.
BERLIN (Reuters) -German medical technology firm Brainlab is planning an initial public offering on the Frankfurt Stock Exchange in the coming weeks, the company said on Thursday.
The Munich-based company said it will list on the regulated market and aims to raise up to 200 million euros ($230 million) through the issuance of new shares.
The firm will use the capital increase to grow its business, with a focus on expanding into additional clinical applications, as well as strengthen its balance sheet.
The current owners also plan to place additional secondary shares to ensure significant free float, said the company.
Majority shareholder Stefan Vilsmeier, who founded the company 35 years ago and recently announced his retirement from the operational business, is set to continue to support the company as a long-term investor.
The initial public offering is being organised by Berenberg, Deutsche Bank, Commerzbank, Jefferies, and UniCredit.
Evercore is also advising the company, which has around 2,000 employees.
Brainlab's main products include software systems that are used as navigational tools by surgeons, for example during brain and hip surgery, and for spinal implants and fractures.
($1 = 0.8678 euros)
(Reporting by Christina Amann and Miranda MurrayEditing by Ludwig Burger)
Brainlab is planning an initial public offering on the Frankfurt Stock Exchange.
The company aims to raise up to 200 million euros, equivalent to about $230 million.
The funds will be used to grow its business, focusing on expanding into additional clinical applications and strengthening its balance sheet.
The IPO is being organized by Berenberg, Deutsche Bank, Commerzbank, Jefferies, and UniCredit, with Evercore also advising the company.
Brainlab's main products include software systems used as navigational tools by surgeons during procedures like brain and hip surgery, as well as for spinal implants and fractures.
Explore more articles in the Finance category
